Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.52
Bid: 1.455
Ask: 1.67
Change: -0.035 (-2.25%)
Spread: 0.215 (14.777%)
Open: 1.52
High: 1.52
Low: 1.52
Prev. Close: 1.555
QED Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Valkor Project Update

19 Apr 2024 07:00

RNS Number : 2352L
Quadrise PLC
19 April 2024
 

19 April 2024

Quadrise Plc ("Quadrise" or the "Company")

Valkor Project Update

Quadrise Plc (AIM: QED), the supplier of innovative energy solutions for a cleaner planet, provides an update on its project with Valkor Technologies LLC ("Valkor") in Utah, USA, which targets the supply of low sulphur MSAR® and bioMSAR™ to the marine and power sector.

Further to the Company's announcement of 2 October 2023, Valkor has now confirmed that their project partner, Heavy Sweet Oil LLC ("HSO"), has received multi-million dollar funding and approval for their Application for Permit to Drill ("APD") from the Utah Division of Oil, Gas and Mining.

The Company understands that Valkor intends to commence drilling of the initial oil well at the Asphalt Ridge in Utah next week, with completion before the end of April. This oil well is expected to yield between 20 and 40 barrels per day of heavy sweet oil. Samples from the first well will be treated to remove impurities and then sent to Quadrise for conversion to MSAR® and bioMSAR™ and for testing. Commercial marketing to the marine, utilities and industrial sectors is expected to commence before the end of Q2 2024 once samples have been received and tested at QRF.

In support of the drilling programme, HSO plans to submit further drilling and Underground Injection Control permit applications for the injection of steam for enhanced recovery with optimised oil well spacing. The latest applications, if approved, will allow for multiple wells to be drilled from the same drill pad, the results of which should enhance the oil field unitisation application for approval of the larger project.

Valkor is managing several conventional oil sands and drilling exploration projects in Utah. With this initial drilling program funded for 3-4 wells, they expect to conclude full project financing and approvals by mid-2024. As previously advised, once a minimum of US$15 million project finance is raised by Valkor, they will pay Quadrise US$1.0 million under the terms of the Site License and Supply Agreement concluded in June 2023. A further US$0.5 million is then due upon delivery of an MSAR® Manufacturing Unit to the project site in Utah, followed by quarterly technology transfer payments of US$75,000.

Commenting on the update, Jason Miles, Chief Executive Officer of Quadrise, said:

"We are delighted to see that Valkor has reached another operational milestone and look forward to the commencement of their drilling operations and the receipt of new heavy sweet oil samples for testing at the Quadrise Research Facility.

The adoption of Quadrise energy decarbonisation technology combined with Valkor's low carbon extraction methods is expected to result in highly marketable low sulphur fuels with compelling economics and environmental credentials."

Steven Byle, Chief Executive Officer of Valkor, added:

"We are very pleased to announce to project stakeholders that the drilling programme is commencing imminently in Utah. We are looking forward to supplying larger samples of heavy sweet oil to commence testing and marketing of MSAR® and bioMSAR™, and to conclude state approvals and project financing of the first production site."

About the Valkor Project

 

The use of low-carbon extraction methods by Valkor in Utah for HSO and other developers is expected to result in heavy sweet oil with a very low well-to-tank carbon intensity. MSAR® produced using this oil is calculated to have a 15-20% lower well-to-wake (or well-to-stack) carbon intensity than conventional very low sulphur fuel oil (VLSFO). The production of bioMSAR™ using renewable glycerine or other biofuel feedstocks would then further reduce fuel carbon intensity. The project is well located to supply local industrial and powerplant consumers, and marine consumers in the west and gulf coasts of the USA via rail, in line with the Company's shipping decarbonisation strategy.

 

For additional information, please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cavendish Capital Markets Limited

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Finlay ThomsonPeter Jacob

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X (formerly Twitter): @QuadrisePlc

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFEFMAELSELL
Date   Source Headline
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
8th Oct 201512:20 pmRNSCompulsory Acqn Procedure
5th Oct 20157:00 amRNSPosting of response circular to increased offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.